JPMorgan Chase & Co’s Virtus LifeSci Biotech Products ETF BBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100
| Closed | -$6.28K | – | 6325 |
|
|
2024
Q3 | $6.28K | Buy |
100
+90
| +900% | +$5.66K | ﹤0.01% | 5391 |
|
|
2024
Q2 | $588 | Buy |
+10
| New | +$588 | ﹤0.01% | 5648 |
|
|
2019
Q3 | – | Sell |
-4,260
| Closed | -$172K | – | 4762 |
|
|
2019
Q2 | $172K | Buy |
4,260
+843
| +25% | +$34K | ﹤0.01% | 3816 |
|
|
2019
Q1 | $153K | Sell |
3,417
-313
| -8% | -$14K | ﹤0.01% | 3859 |
|
|
2018
Q4 | $130K | Sell |
3,730
-10
| -0.3% | -$349 | ﹤0.01% | 3946 |
|
|
2018
Q3 | $169K | Sell |
3,740
-87
| -2% | -$3.93K | ﹤0.01% | 3924 |
|
|
2018
Q2 | $168K | Sell |
3,827
-64
| -2% | -$2.81K | ﹤0.01% | 3890 |
|
|
2018
Q1 | $161K | Buy |
3,891
+37
| +1% | +$1.53K | ﹤0.01% | 3784 |
|
|
2017
Q4 | $156K | Buy |
3,854
+275
| +8% | +$11.1K | ﹤0.01% | 3755 |
|
|
2017
Q3 | $147K | Buy |
3,579
+516
| +17% | +$21.2K | ﹤0.01% | 3545 |
|
|
2017
Q2 | $121K | Buy |
3,063
+807
| +36% | +$31.9K | ﹤0.01% | 3514 |
|
|
2017
Q1 | $85K | Buy |
+2,256
| New | +$85K | ﹤0.01% | 3780 |
|